Search
for
Sort by
Research 30 of 1000+
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Topical Janus kinase inhibitors: A review of applications in dermatology
- Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
- Janus Kinase inhibitors in dermatology: a review
- Janus kinase inhibitors for alopecia areata: A narrative review
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Janus Kinase Inhibitors for Alopecia Areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- A review of Janus kinase inhibitor use in scarring alopecia
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Emerging drugs for alopecia areata: JAK inhibitors
- Topical tofacitinib in treatment of alopecia areata
- 691 Topical curcumin promotes induction of the murine hair cycle
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata